Dose-related effects of the peroxisome proliferator methylclofenapate in rat liver

Author： Lake B.G.   Rumsby P.C.   Cunninghame M.E.   Price R.J.  

Publisher： Elsevier

ISSN： 1382-6689

Source： Environmental Toxicology and Pharmacology, Vol.11, Iss.3, 2002-07, pp. : 233-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose-related inversion of cinnarizine and flunarizine effects on mitochondrial permeability transition

By Elimadi A.   Bouillot L.   Sapena R.   Tillement J.-P.   Morin D.  

European Journal of Pharmacology, Vol. 348, Iss. 1, 1998-05 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite

Thalidomide-induced peripheral neuropathy dose-related?

By  

Reactions Weekly, Vol. 1, Iss. 1013, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat

By Konturek P.C.   Brzozowski T.   Kania J.   Konturek S.J.   Kwiecien S.   Pajdo R.   Hahn E.G.  

European Journal of Pharmacology, Vol. 472, Iss. 3, 2003-07 ,pp. : 213-220

Elsevier

Access to resources Recommend Favorite

Peroxisome proliferator activated receptors and obesity

By Kersten S.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 223-234

Elsevier

Access to resources Recommend Favorite

Impact of α-lipoic acid on liver peroxisome proliferator-activated receptor-α, vascular remodeling, and oxidative stress in insulin-resistant rats

By El Midaoui Adil   Lungu Calin   Wang Hui   Wu Lingyun   Robillard Caroline   DeBlois Denis   Couture Réjean  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 10, 2011-10 ,pp. : 743-751

NRC Research Press

Access to resources Recommend Favorite